Celebrating 30 years of helping you give wisely
America's most independent,
assertive charity watchdog
Top Rated

Pancreatic Cancer Action Network

CharityWatch report issued
October 2022

Top-Rated Charity
A
CharityWatch Grade
Our independent grade based
on a number of factors.
 
80%
Program Percentage
Amount spent on programs
relative to overhead.
 
$13
Cost to Raise $100
Amount spent to raise
$100 of contributions.

Contact Information

Pancreatic Cancer Action Network
1500 Rosecrans Avenue
Suite 200
Manhattan Beach, CA 90266

Other Names

None

Tax Status

501(c)3

Website

www.pancan.org

Stated Mission

To advance research, support patients, and create hope for people who have pancreatic cancer.

View similar charities
Charity  
American Breast Cancer Foundation  
American Cancer Society  
American Institute for Cancer Research  
Avon Products Foundation  
Breast Cancer Charities of America (DISSOLVED)  
Breast Cancer Outreach Foundation (DISSOLVED)  
Breast Cancer Prevention Partners  
Breast Cancer Research Foundation  
Breast Cancer Society (DISSOLVED)  
Cancer Fund of America (DISSOLVED)  
Cancer Recovery Foundation International  
Cancer Research Institute  
Cancer Survivors' Fund  
CancerCare  
Childhood Leukemia Foundation  
Children's Cancer Fund of America (DISSOLVED)  
Children's Cancer Recovery Foundation (DISSOLVED)  
Children's Cancer Research Fund  
Children's Leukemia Research Association  
CureSearch for Children's Cancer  
Damon Runyon Cancer Research Foundation  
Dana-Farber Cancer Institute  
Entertainment Industry Foundation / Stand Up To Cancer  
Good Charity (DISSOLVED)  
Leukemia & Lymphoma Society  
Livestrong Foundation  
Memorial Sloan Kettering Cancer Center  
Multiple Myeloma Research Foundation  
National Breast Cancer Coalition Fund  
National Breast Cancer Foundation  
National Cancer Assistance Foundation  
National Cancer Center  
National Cancer Coalition (DISSOLVED)  
National Children's Cancer Society  
National Children's Leukemia Foundation (DISSOLVED)  
National Foundation for Cancer Research  
Ovarian Cancer Research Alliance  
Prevent Cancer Foundation  
Prostate Cancer Foundation  
St. Jude Children's Research Hospital  
Susan G. Komen Breast Cancer Foundation  
United Breast Cancer Foundation  
United Cancer Support Foundation  
Walker Cancer Research Institute  
Woman to Woman Breast Cancer Foundation (DISSOLVED)  
Data based on Fiscal Year Ended 06/30/2021

Program Percentage: 80%

The percentage of Pancreatic Cancer Action Network's cash budget it spends on programs relative to overhead (fundraising, management, and general expenses).

$41,000,000

Calculated Total Expenses

(rounded)

 

Cost to Raise $100: $13

How many dollars Pancreatic Cancer Action Network spends on fundraising to raise each $100 of contributions.

$36,000,000

Calculated Total Contributions

(rounded)

Government Funding

0% to 24%

Percentage of cash revenue
coming from government sources

 

Financial Documents

Entity Document Type Tax ID
Pancreatic Cancer Action Network IRS Form 990 33-0841281
Pancreatic Cancer Action Network Audited Financial Statements 33-0841281
Entity: Pancreatic Cancer Action Network
Document Type: IRS Form 990
Tax ID: 33-0841281
Entity: Pancreatic Cancer Action Network
Document Type: Audited Financial Statements
Tax ID: 33-0841281

Governance & Transparency

CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
This charity is Top-Rated
What does it mean to be Top-Rated?
 
Pancreatic Cancer Action Network
meets governance benchmarks.
 
Pancreatic Cancer Action Network
meets transparency benchmarks.
Transparency
Provides Financial Information
Audit Accessibility
Governance: Policies
Reports regularly & consistently monitoring & enforcing compliance with a written Conflict of Interest Policy
Reports required, annual disclosure by officers, directors, and key staff of interests that could give rise to conflicts
Reports having a written Whistleblower Policy
Reports having a written Document Retention and Destruction Policy
Governance: Financials
Reports providing copy of tax form to all board members prior to filing it with IRS
Reports that financial statements were audited by an independent accountant
Governance: Board of Directors
Reports at least 5 voting board members
51% or more of voting board members reported as independent
Reports documenting minutes of board and board committee meetings
Privacy Policy
Privacy Policy Opt-Out Policy  

  Name Title Compensation
1 Julie Fleshman President/CEO $804,892
2 Sudheer Doss Chief Data Officer $389,829
3 Thomas Croal CFO $371,721
1
Name: Julie Fleshman
Title: President/CEO
Compensation: $804,892
2
Name: Sudheer Doss
Title: Chief Data Officer
Compensation: $389,829
3
Name: Thomas Croal
Title: CFO
Compensation: $371,721

CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.

According to the Pancreatic Cancer Action Network audit of June 30, 2021 (Note 8, Note Payable):

"In March 2020, Congress passed the Paycheck Protection Program, authorizing loans to small businesses for use in paying employees that they continue to employ throughout the COVID-19 pandemic and for rent, utilities and interest on mortgages. Loans obtained through the Paycheck Protection Program are eligible to be forgiven as long as the proceeds are used for qualifying purposes and certain other conditions are met.

"In June 2020, the Organization received loan proceeds in the amount of $1,950,000 under the Paycheck Protection Program (PPP). The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act ('CARES Act'), provides for loans to qualifying business for amounts up to 2.5 times of the average monthly payroll expenses of the qualifying business. On August 6, 2021, the Small Business Administration approved forgiveness of the PPP loan in full. The Organization will recognize income from the forgiveness of the PPP loan during the year ended June 30, 2022."

According to the Pancreatic Cancer Action Network audit of June 30, 2021 (Note 9, Commitments and Contingencies, Business Risks Associated with the Impact of COVID-19):

"The spread of the coronavirus has resulted in federal, state and local governments mandating various restrictions on public gatherings and stay-at-home orders. Because of the severity and global nature of the COVID-19 pandemic, the impact on the Organization's business could be significant and have a material impact on its financial position and operating results going forward. Certain events and programming have been postponed or rescheduled to accommodate remote attendance. Management continues to evaluate the potential future impact on its business and financial statements."

According to the Pancreatic Cancer Action Network (PCAN) tax filing for the fiscal year ended June 30, 2021, PCAN reports re: Compensation, Supplemental Information (IRS Form 990, Schedule J, Part III):

Regarding severance payments to officers, directors, trustees, key employees and highest compensated employees (Schedule J, Part I, line 4a):

"The following individual received a severance payment during fiscal year eneded [sic] June 30, 2020: Victoria Manax $131,213."

[Victoria Manax is reported as "Former (thru 2/14/20)," with total compensation of $187,469 in calendar year 2020 (Schedule J, Part II).]


Regarding the payment or accrual of any compensation to officers, directors, trustees, key employees and highest compensated employees contingent on the revenues of the organization (Schedule J, Part I, line 5a):

"The performance incentive plan incentivizes our valued team members if certain revenue achievements are reached."


PCAN reports "Bonus & incentive compensation" payments to nine individuals in calendar year 2020, including $85,163 paid to Julie Fleshman, President & CEO, whose reported total compensation in 2020 is $804,892. The other eight reported "Bonus & incentive compensation" payments range from $46,770 to $25,245, with associated reported total compensation ranging from $389,829 to $267,521 (IRS Form 990, Schedule J, Part II).


Related Articles

No related articles found